Cupping Therapy on Immune System in Post Covid -19

Summary

Purpose of this study is to investigate

1. The effect of Dry cupping therapy on T-Lymphocyte in post covid-19 patients.
2. The effect of Dry cupping therapy on serum Cytokine in post covid-19 patients.
3. The effect of Dry cupping therapy on Immunoglobulin IgA.
4. The effect of Dry cupping therapy on Immunoglobulin IgM.
5. The effect of Dry cupping therapy on Immunoglobulin IgG. seventy six patients of both genders with deficiency in T-Lymphocyte number,,higher level of serum cytokine and lower immunoglobulin IgA,IgM,IgG after two weeks of recovery from covid-19 . Age range from Twenty one to Sixty six years old .They participated in the study and recruited from surveillance unit of Shobra general hospital .These patients recruited by phone and have been offered to participate in the programme.The patients were divided equally into two groups (A and B). Assessment was done before and after treatment. T-Lymphocyte, serum cytokine and immunoglobulin IgA, IgM and IgG were analyzed by kenza 240 TX from fluorescence-labeled flow cytometry. Disposable cupping therapy instrument was used in treatment of group (A) in addition to traditional medical treatment in the form of vitamin C, D and anticoagulant drugs. Traditional medical treatment only was used in treatment of group (B).The obtained results of this study will determine the significant improvement of participated two groups.

.

Conditions

• Covid-19 Patients

Interventions

COMBINATION_PRODUCT

Cupping therapy with convential medical treatment

Device:Cupping therapy device Group A participants received Dry cupping therapy one session per week for 8 weeks with 6 days intervals between sessions and with cups applied to the skin for around 8 minutes. (In addition to convential medical treatment for 8 weeks in the form of : 1. Vitamin D: The recommended dietary dose of vitamin D is 600 IU each day for adults 70 and younger . 2. Vitamine C: The recommended dietary dose 200 mg/day vitamin c 3. Anticoagulation drugs ("blood thinners")Doctors usually prescribe low-molecular-weight heparin (enoxaparin) (30 mg), each given subcutaneously every 12 hours .

DRUG

Convential medical treatment

Group B participants received convential medical treatment for 8 weeks in the form of : 1. Vitamin D: The recommended dietary dose of vitamin D is 600 IU each day for adults 70 and younger . 2. Vitamine C: The recommended dietary dose 200 mg/day vitamin C 3. Anticoagulation drugs ("blood thinners")Doctors usually prescribe low-molecular-weight heparin (enoxaparin) (30 mg), each given subcutaneously every 12 hours .

Sponsors & Collaborators

• Cairo University

  lead OTHER

Principal Investigators

• Marwa Mohamed, master · Physiotherapist at Shoubra general hospital

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

21 Years

Max Age

66 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2022-03-07

Primary Completion

2022-06-21

Completion

2023-06-01

Countries

• Egypt

Study Locations